Biosurgery Market is expanding at a CAGR of 5.5% forecast to 2022 - 2031 | Tissue Regenix Group Plc, Meril Lifesciences Pvt. Ltd, Becton, Dickinson & Co., Johnson & Johnson

The global Biosurgery Market size was USD 12.4 Bn in 2021 and is anticipated to reach USD 21.2 Bn in 2031, growing at a rate of 5.5% from 2022 to 2031.

To Remain 'Ahead' Of Your Competitors, Request for a Sample - https://www.globalinsightservices.com/request-sample/GIS10242?utm_source=sidram&utm_medium=openpr&utm_campaign=13122023

Biosurgery is a medical procedure that comprises the use of natural, synthetic, or semi-synthetic materials to seal surgical incisions and wounds. It is majorly used for preventing excessive blood loss, providing adhesion for wound and tissue sealing, and repairing damaged tissue and bones.

Biosurgeries are usually conducted through the various hemostatic sealants, soft tissue repair, bone graft substitutes, adhesion prevention, and staple line reinforcement products. They also utilize natural allografts, cultured epithelial autografts, cultured epithelial autografts, and xenografts for minimizing intra and post-operative complications and promoting faster recovery of the patients.

Read More Report of Biosurgery Market : https://www.globalinsightservices.com/reports/biosurgery-market/?utm_source=sidram&utm_medium=openpr&utm_campaign=13122023

Market Trends and Drivers

The major factors boosting the growth of the biosurgery market is the increasing volume of surgeries and the growing prevalence of severe trauma injuries. Adhesion formation is a major post-surgical complication, which results in healthcare complications and generally requires repeat surgeries for the treatment of affected patients.

Post-surgical adhesion formation leads to different complications in different surgeries, like severe abdominal pain in the case of abdominal surgeries, infertility in women after gynaecological surgeries, and physical impairment of patients after neurological surgeries.

Get a customized scope to match, your need ask an expert - https://www.globalinsightservices.com/request-customization/GIS10242?utm_source=sidram&utm_medium=openpr&utm_campaign=13122023

Considering the severe effects of post-surgery adhesion formation in patients, the importance of products such as adhesion barriers is increasing in the market. Also, considering the growth in the number of surgeries performed globally, the importance of these products will be more prominent in the forthcoming years.

For In-Depth Competitive Analysis, Purchase this Report - https://www.globalinsightservices.com/checkout/single_user/GIS10242?utm_source=sidram&utm_medium=openpr&utm_campaign=13122023

Likewise, the growing adoption of advanced biosurgery products in emerging markets is also boosting the growth of the biosurgery market. The penetration of biosurgery products is increasing across emerging countries, specifically based in the Asia Pacific, Latin America, and the Middle East and Africa. In the coming years, countries such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the biosurgery market.

This is because the markets in these countries are characterized by a large patient base for target indications (like cardiovascular, orthopedic, general/abdominal, and gynecologic disorders), rising health awareness, growing healthcare expenditure, rising medical tourism, coupled with rapidly developing healthcare infrastructure. Over the last few decades, countries such as India and Malaysia have emerged as hubs for medical tourism.

This is because the cost of medical procedures across these emerging countries is significantly less in comparison to developed countries such as the US, Germany, France, and the UK. Moreover, government agencies in several Asia Pacific and Middle East countries are undertaking initiatives to support their respective healthcare systems, which is providing lucrative growth opportunities to the biosurgery product manufacturers across emerging countries.

Market Segments

By Product

Bone-graft Substitutes
Soft-tissue Attachments
Hemostatic Agents
Surgical Sealants & Adhesives
Adhesion Barriers
Staple-Line Reinforcement Agents

By Application

Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Reconstructive Surgery
Gynecological Surgery
Urological Surgery
Thoracic Surgery
Others

By End Users

Hospitals
Clinics
Others

Major Players of the Global Biosurgery Market

The global biosurgery market report includes players such as Johnson & Johnson (US), Baxter International Inc. (US), Medtronic Plc (Ireland), Becton, Dickinson & Co. (US), B. Braun Melsungen AG (Germany), Stryker Corp. (US), Integra Lifesciences Holdings Corp. (US), CSL Ltd. (Australia), Hemostasis LLC. (US), Pfizer Inc. (US), Cyrolife Inc. (US), Zimmer Biomet (US), Kuros Biosciences AG (Switzerland), Orthofix Medical Inc. (US), Smiths & Nephew Plc. (UK), Tissue Regenix Group Plc (UK), Betatech Medical (Turkey), Meril Lifesciences Pvt. Ltd. (India), RTI Surgicals (US), Samyang Holdings Corp. (South Korea), Aroa Biosurgery Ltd. (New Zealand), Meyer-Haake GmbH (Germany), Biom'Up (France), BioCer Entwicklungs-GmbH (Germany), and Hannox International Corp. (Taiwan) among others.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.